Obesity is endocrinologically responsible for the physiological consequences of less insulin sensitivity followed by hyperinsulinemia, glucose intolerance, proinflammation, hepatic steatosis, dyslipidemia, tumorigenicity, and metastasis [112]. This evidence concerns the gene INS and metabolic syndrome.